Regulatory assistance available to Small and Medium-sized Enterprises (SMEs)

pharmafile | January 12, 2011 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing  

The increasing number of SMEs in Europe is seen to be a driving force to facilitate economic growth, new product development, social integration and employment. This includes the pharmaceutical industry for which there is a pool of resources available to assist the growth of SMEs, including the European Medicines Agency’s recently launched public registry providing information on registered SMEs.

Wainwright Associates are experts in assisting eligible companies achieve SME status and supporting them throughout all phases of drug development, regulatory affairs, pharmacovigilance and licensing. Our specialist consultants will help you make the most of the incentives that are available in Europe, and we are flexible to meet any requirements that you or your company may have.

If you would like any assistance or advice, please contact Wainwright Associates at enquiries@wainwrightassociates.co.uk or +44 1628 530554.

www.wainwrightassociates.com

 

Related Content

No items found
The Gateway to Local Adoption Series

Latest content